SCPH – scpharmaceuticals inc. (US:NASDAQ)
Stock Stats
News
scPharmaceuticals Inc. (NASDAQ: SCPH) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $18.00 price target on the stock.
scPharmaceuticals Inc. (NASDAQ: SCPH) had its price target lowered by analysts at Craig Hallum from $16.00 to $12.00. They now have a "buy" rating on the stock.
scPharmaceuticals Inc. Reports Third Quarter 2024 Financial Results and Provides Business Update
scPharmaceuticals to Announce Third Quarter 2024 Financial Results on Wednesday, November 13, 2024
scPharmaceuticals to Host Key Opinion Leader (KOL) Webinar on October 22, 2024
Form SC 13G/A scPharmaceuticals Inc. Filed by: KING LUTHER CAPITAL MANAGEMENT CORP
Form SC 13G/A scPharmaceuticals Inc. Filed by: Lundbeckfond Invest A/S
Form SC 13G/A scPharmaceuticals Inc. Filed by: LYTTON LAURENCE W
Form 10-Q scPharmaceuticals Inc. For: Sep 30
Form 8-K scPharmaceuticals Inc. For: Nov 13
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.